DWA
BIO icon

Dorsey Wright & Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History

Dorsey Wright & Associates’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,410
Closed -$2.58M – 289
2021
Q4 		$2.58M Buy
+3,410
New +$2.55M 0.53% 90
2019
Q1 		– Sell
-6,620
Closed -$1.54M – 293
2018
Q4 		$1.54M Sell
6,620
-16,872
-72% -$4.53M 0.46% 86
2018
Q3 		$7.35M Buy
23,492
+15,059
+179% +$4.67M 1.34% 20
2018
Q2 		$2.43M Buy
8,433
+78
+0.9% +$21.5K 0.36% 81
2018
Q1 		$2.09M Buy
8,355
+86
+1% +$21.9K 0.32% 83
2017
Q4 		$1.97M Sell
8,269
-7,514
-48% -$1.82M 0.36% 88
2017
Q3 		$3.51M Buy
15,783
+7,834
+99% +$1.76M 0.81% 63
2017
Q2 		$1.8M Buy
+7,949
New +$1.73M 0.55% 81

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return